Disease on EC 3.4.13.18 - cytosol nonspecific dipeptidase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Adenocarcinoma
Prolidase and prolinase activities in moderately and poorly differentiated lung adenocarcinoma.
Adenocarcinoma of Lung
Prolidase and prolinase activities in moderately and poorly differentiated lung adenocarcinoma.
Carcinoma
Quantitative proteomics approach to screening of potential diagnostic and therapeutic targets for laryngeal carcinoma.
Carcinoma, Hepatocellular
Effect of ethanol on prolidase I and prolinase activity in the human hepatoma cell line Hep G2.
Carcinoma, Hepatocellular
Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
Diabetes Mellitus, Type 1
Exclusion of polymorphisms in carnosinase genes (CNDP1 & CNDP2) as cause of diabetic nephropathy in type 1 diabetes mellitus. Results of large case - control and follow - up studies.
Diabetes Mellitus, Type 2
Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes.
Diabetic Nephropathies
Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes.
Diabetic Nephropathies
Exclusion of polymorphisms in carnosinase genes (CNDP1 & CNDP2) as cause of diabetic nephropathy in type 1 diabetes mellitus. Results of large case - control and follow - up studies.
Diabetic Nephropathies
Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.
Diabetic Nephropathies
The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans.
Fibrosarcoma
Activity of lysosomal and nonlysosomal proteases of fibrosarcoma induced by methylcholanthrene.
Hepatitis, Chronic
Determination of prolinase activity in plasma. Application to liver disease and its relation with prolidase activity.
Infections
Changes in the intestinal enzyme activity of lambs during chronic infection with Trichostrongylus vitrinus.
Liver Diseases
Determination of prolinase activity in plasma. Application to liver disease and its relation with prolidase activity.
Liver Diseases, Alcoholic
Plasma prolidase and prolinase activity in alcoholic liver disease.
Neoplasm Metastasis
CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway.
Neoplasm Metastasis
Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
Neoplasm Metastasis
Quantitative proteomics approach to screening of potential diagnostic and therapeutic targets for laryngeal carcinoma.
Neoplasms
A toolset to study functions of Cytosolic non-specific dipeptidase 2 (CNDP2) using Drosophila as a model organism.
Neoplasms
Activity of lysosomal and nonlysosomal proteases and contents of protein and its degradation products in the blood serum of rats with fibrosarcoma induced by methylcholanthrene.
Neoplasms
Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
Neoplasms
Underexpressed CNDP2 participates in gastric cancer growth inhibition through activating the MAPK signaling pathway.
Obesity
The Combined Effects of Genetic Variation in the CNDP1 and CNDP2 Genes and Dietary Carbohydrate and Carotene Intake on Obesity Risk.
Ovarian Neoplasms
CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway.
Parkinson Disease
Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease.
Prolidase Deficiency
Biochemical investigations on prolidase and prolinase in erythrocytes from patients with prolidase deficiency.
Prolidase Deficiency
Characteristics and partial purification of prolidase and prolinase from leukocytes of a normal human and a patient with prolidase deficiency.
Prolidase Deficiency
Characteristics of prolinase against various iminodipeptides in erythrocyte lysates from a normal human and a patient with prolidase deficiency.
Stomach Neoplasms
Underexpressed CNDP2 participates in gastric cancer growth inhibition through activating the MAPK signaling pathway.
Uremia
Prolidase and prolinase activities in the erythrocytes of patients with chronic uremia.
xaa-pro dipeptidase deficiency
Biochemical investigations on prolidase and prolinase in erythrocytes from patients with prolidase deficiency.
xaa-pro dipeptidase deficiency
Characteristics and partial purification of prolidase and prolinase from leukocytes of a normal human and a patient with prolidase deficiency.
xaa-pro dipeptidase deficiency
Characteristics of prolinase against various iminodipeptides in erythrocyte lysates from a normal human and a patient with prolidase deficiency.
xaa-pro dipeptidase deficiency
Plasma prolidase and prolinase activity in prolidase deficiency.
html completed